Association between fibrinogen/albumin ratio and arterial stiffness in patients with type 2 diabetes: A

Chun-Mei Chen1, Chun-Feng Lu2, Wang-Shu Liu2

  • 1Department of Geriatrics, Affiliated Hospital 2 of Nantong University and First People's Hospital of Nantong City, Nantong, China.

Frontiers in Pharmacology
|January 30, 2023
PubMed

Insights

The fibrinogen albumin ratio (FAR) is linked to arterial stiffness in men with type 2 diabetes. This ratio may help detect arterial stiffness in male T2D patients.

Area of Science:

  • Cardiovascular Medicine
  • Endocrinology
  • Biomarkers

Background:

  • Fibrinogen albumin ratio (FAR) correlates with cardiovascular disease (CVD) severity and prognosis.
  • Arterial stiffness, an early CVD lesion, has not been previously linked to FAR.
  • Investigating the relationship between FAR and arterial stiffness in type 2 diabetes (T2D) is crucial.

Purpose of the Study:

  • To examine the relationship between FAR and arterial stiffness in T2D patients.
  • To assess arterial stiffness using brachial-ankle pulse wave velocity (baPWV).
  • To determine if FAR is an independent predictor of arterial stiffness in T2D.

Main Methods:

  • Cross-sectional study of 413 T2D patients (Jan 2021-Apr 2022).
  • Measured serum fibrinogen, albumin, and baPWV.
  • Defined arterial stiffness as baPWV > 1800 cm/s.

Main Results:

  • 18.6% of T2D patients had arterial stiffness.
  • Significant differences in baPWV and arterial stiffness proportion across FAR quartiles (p < .001).
  • FAR independently associated with arterial stiffness in men with T2D (OR 1.075; 95% CI 1.031-1.120).
  • Optimal FAR cutoff for arterial stiffness in men: 76.67 mg/g.

Conclusions:

  • FAR shows an independent, positive correlation with arterial stiffness in male T2D patients.
  • This correlation was not observed in female T2D patients.
  • FAR may serve as a potential biomarker for arterial stiffness in men with T2D.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
44
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
24
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.6K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
26
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
16
Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
3.4K